Short-term intermittent hypoxia induces simultaneous systemic insulin resistance and higher cardiac contractility in lean mice.
cardiac function
cardiac remodeling
hyperinsulinemia
intermittent hypoxia
obstructive sleep apnea
Journal
Physiological reports
ISSN: 2051-817X
Titre abrégé: Physiol Rep
Pays: United States
ID NLM: 101607800
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
received:
11
12
2020
revised:
07
01
2021
accepted:
08
01
2021
entrez:
8
3
2021
pubmed:
9
3
2021
medline:
21
12
2021
Statut:
ppublish
Résumé
Intermittent hypoxia (IH) is the major feature of obstructive sleep apnea syndrome, well-known to induce cardiometabolic complications. We previously demonstrated that IH induces hyperinsulinemia and associated altered insulin signaling in adipose tissue, liver, and skeletal muscle, but impact of IH on cardiac insulin signaling and functional/structural consequences remains unknown. Therefore, the aims of this study were to investigate in both lean and obese mice the effects of chronic IH on the following: (1) cardiac insulin signaling and (2) cardiac remodeling and function. C57BL/6 J male mice were fed low-fat (LFD) or high-fat (HFD) diet for 20 weeks, and exposed to IH (21-5% FiO2, 60 s cycle, 8 h/day) or normoxia (N) for the last 6 weeks. Systemic insulin sensitivity was evaluated by an insulin tolerance test. Cardiac remodeling and contractile function were assessed by cardiac ultrasonography. Ultimately, hearts were withdrawn for biochemical and histological analysis. In LFD mice, IH-induced hyperinsulinemia and systemic insulin resistance that were associated with increased phosphorylations of cardiac insulin receptor and Akt on Tyr1150 and Ser473 residues, respectively. In addition, IH significantly increased cardiac interstitial fibrosis and cardiac contractility. In the HFD group, IH did not exert any additional effect, nor on insulin/Akt signaling, nor on cardiac remodeling and function. Our study suggests that, despite systemic insulin resistance, IH exposure mediates an adaptive cardiac response in lean but not in obese mice. Further studies are needed to investigate which specific mechanisms are involved and to determine the long-term evolution of cardiac responses to IH.
Sections du résumé
BACKGROUND
Intermittent hypoxia (IH) is the major feature of obstructive sleep apnea syndrome, well-known to induce cardiometabolic complications. We previously demonstrated that IH induces hyperinsulinemia and associated altered insulin signaling in adipose tissue, liver, and skeletal muscle, but impact of IH on cardiac insulin signaling and functional/structural consequences remains unknown. Therefore, the aims of this study were to investigate in both lean and obese mice the effects of chronic IH on the following: (1) cardiac insulin signaling and (2) cardiac remodeling and function.
METHODS
C57BL/6 J male mice were fed low-fat (LFD) or high-fat (HFD) diet for 20 weeks, and exposed to IH (21-5% FiO2, 60 s cycle, 8 h/day) or normoxia (N) for the last 6 weeks. Systemic insulin sensitivity was evaluated by an insulin tolerance test. Cardiac remodeling and contractile function were assessed by cardiac ultrasonography. Ultimately, hearts were withdrawn for biochemical and histological analysis.
RESULTS
In LFD mice, IH-induced hyperinsulinemia and systemic insulin resistance that were associated with increased phosphorylations of cardiac insulin receptor and Akt on Tyr1150 and Ser473 residues, respectively. In addition, IH significantly increased cardiac interstitial fibrosis and cardiac contractility. In the HFD group, IH did not exert any additional effect, nor on insulin/Akt signaling, nor on cardiac remodeling and function.
CONCLUSION
Our study suggests that, despite systemic insulin resistance, IH exposure mediates an adaptive cardiac response in lean but not in obese mice. Further studies are needed to investigate which specific mechanisms are involved and to determine the long-term evolution of cardiac responses to IH.
Identifiants
pubmed: 33682327
doi: 10.14814/phy2.14738
pmc: PMC7937943
doi:
Substances chimiques
Blood Glucose
0
Insulin
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14738Informations de copyright
© 2021 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.
Références
J Appl Physiol (1985). 2012 Sep 1;113(5):791-8
pubmed: 22773770
J Appl Physiol (1985). 2009 Sep;107(3):787-93
pubmed: 19589954
Sci Rep. 2018 Feb 14;8(1):2997
pubmed: 29445096
Am J Physiol Heart Circ Physiol. 2015 Oct;309(7):H1101-11
pubmed: 26232233
Toxicol Appl Pharmacol. 2014 May 15;277(1):58-66
pubmed: 24657099
Eur Respir J. 2011 Jan;37(1):119-28
pubmed: 20525723
Oxid Med Cell Longev. 2012;2012:569520
pubmed: 22685619
Diabetes. 2017 Dec;66(12):2942-2951
pubmed: 28882901
Int Immunopharmacol. 2003 Sep;3(9):1247-55
pubmed: 12890422
Am J Physiol Heart Circ Physiol. 2016 Jan 15;310(2):H279-89
pubmed: 26566725
J Clin Invest. 2010 May;120(5):1506-14
pubmed: 20407209
J Physiol. 2017 Mar 15;595(6):1973-1986
pubmed: 27983752
J Appl Physiol (1985). 2008 Jan;104(1):218-23
pubmed: 18006871
Heart Fail Rev. 2009 Dec;14(4):225-41
pubmed: 19110970
Eur Heart J. 2010 Jan;31(1):100-11
pubmed: 19797329
J Appl Physiol (1985). 2010 Dec;109(6):1675-85
pubmed: 20947716
Eur Respir J. 2017 Apr 19;49(4):
pubmed: 28424360
Circ Res. 2016 Apr 1;118(7):1151-69
pubmed: 27034277
J Am Coll Cardiol. 2013 Aug 13;62(7):569-76
pubmed: 23770180
Nat Rev Dis Primers. 2015 Jun 25;1:15015
pubmed: 27188535
Physiol Rep. 2014 Apr 22;2(4):e12001
pubmed: 24771695
Am J Respir Crit Care Med. 2005 Oct 1;172(7):915-20
pubmed: 15976378